financetom
Business
financetom
/
Business
/
Moderna ends development of CMV vaccine after trial failure
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moderna ends development of CMV vaccine after trial failure
Oct 22, 2025 2:04 PM

Oct 22 (Reuters) - Moderna ( MRNA ) said on Wednesday it

will discontinue development of its experimental vaccine to

prevent cytomegalovirus, a common cause of birth defects, after

it failed to meet the main goal of a late-stage trial.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zoom Delivers Beat-And-Raise Quarter; AI/CX Growth Engines Are 'Firing On All Cylinders,' Analysts Say
Zoom Delivers Beat-And-Raise Quarter; AI/CX Growth Engines Are 'Firing On All Cylinders,' Analysts Say
Nov 25, 2025
Shares of Zoom Communications Inc ( ZM ) climbed in early trading on Tuesday, after the company reported upbeat third-quarter earnings. Here are some key analyst takeaways: Needham analyst Joshua Reilly maintained a Buy rating and price target of $100. Rosenblatt Securities analyst Catharine Trebnick reiterated a Buy rating and price target of $115. Check out other analyst stock ratings....
Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary
Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary
Nov 25, 2025
MELBOURNE, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. ( BLEG ) , a leader in innovative addiction treatment and harm reduction solutions, today announced that its newly acquired subsidiary, Pau Hana, posted strong third quarter revenues of just over one hundred and twenty-five thousand dollars ($125,000.00). Branded Legacy ( BLEG ) intends to aggressively...
Form 8.3
Form 8.3
Nov 25, 2025
BOSTON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity Fund) (b) Owner or controller of interests...
Zoom Communications Posted Solid Q3 Results, Seeing High Demand for AI Products, Wedbush Says
Zoom Communications Posted Solid Q3 Results, Seeing High Demand for AI Products, Wedbush Says
Nov 25, 2025
10:36 AM EST, 11/25/2025 (MT Newswires) -- Zoom Communications ( ZM ) delivered fiscal Q3 results with solid beats on the top and bottom lines as the company is seeing elevated demand for its artificial intelligence products, Wedbush Securities said in a note Tuesday. The company's Q3 revenue at $1.23 billion was above both market expectations and Zoom's own guidance...
Copyright 2023-2026 - www.financetom.com All Rights Reserved